Your browser is no longer supported. Please, upgrade your browser.
CPIX [NASD]
Cumberland Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.20 Insider Own42.00% Shs Outstand14.88M Perf Week-13.01%
Market Cap54.18M Forward P/E- EPS next Y- Insider Trans0.83% Shs Float8.26M Perf Month-23.71%
Income-2.90M PEG- EPS next Q- Inst Own18.90% Short Float7.27% Perf Quarter27.72%
Sales37.90M P/S1.43 EPS this Y27.80% Inst Trans-0.23% Short Ratio0.12 Perf Half Y4.60%
Book/sh3.15 P/B1.08 EPS next Y- ROA-0.60% Target Price- Perf Year3.33%
Cash/sh1.62 P/C2.10 EPS next 5Y30.00% ROE-1.20% 52W Range2.20 - 7.51 Perf YTD-26.98%
Dividend- P/FCF10.62 EPS past 5Y-64.60% ROI-10.40% 52W High-54.59% Beta0.12
Dividend %- Quick Ratio2.10 Sales past 5Y2.20% Gross Margin80.90% 52W Low55.00% ATR0.38
Employees90 Current Ratio2.60 Sales Q/Q-12.90% Oper. Margin-13.20% RSI (14)36.68 Volatility6.85% 8.48%
OptionableYes Debt/Eq0.00 EPS Q/Q-25.30% Profit Margin-1.40% Rel Volume0.03 Prev Close3.66
ShortableYes LT Debt/Eq0.32 EarningsNov 09 AMC Payout- Avg Volume5.06M Price3.41
Recom3.00 SMA20-22.48% SMA50-14.59% SMA2007.29% Volume133,956 Change-6.83%
Nov-12-12Reiterated UBS Neutral $6.50 → $5
Feb-01-11Reiterated UBS Neutral $8 → $6.50
Dec-16-10Downgrade UBS Buy → Neutral $10 → $8
Aug-17-10Reiterated UBS Buy $11 → $10
Aug-17-10Reiterated Morgan Joseph Buy $15 → $10
Aug-17-10Downgrade Jefferies Buy → Hold $13 → $5.50
May-14-10Reiterated Morgan Joseph Buy $21 → $15
Jan-04-22 05:09PM  
09:15AM  
Dec-01-21 05:06AM  
Nov-30-21 11:02AM  
05:08AM  
Nov-29-21 04:05PM  
Nov-16-21 02:27PM  
Nov-09-21 04:05PM  
Nov-08-21 08:25AM  
Nov-02-21 04:05PM  
Oct-04-21 08:17AM  
Sep-29-21 09:25AM  
Aug-10-21 06:15PM  
04:05PM  
Aug-03-21 04:05PM  
03:00PM  
Jul-26-21 09:25AM  
Jun-22-21 09:15AM  
06:46AM  
Jun-21-21 09:20AM  
08:33AM  
Jun-18-21 11:56AM  
Jun-17-21 09:40AM  
Jun-02-21 12:45PM  
May-19-21 03:30PM  
May-11-21 04:05PM  
02:30PM  
May-04-21 04:05PM  
Mar-09-21 06:45PM  
04:26PM  
04:05PM  
01:30PM  
Mar-08-21 10:08AM  
Mar-02-21 04:05PM  
Feb-17-21 12:59AM  
Nov-27-20 05:22PM  
Nov-17-20 11:05AM  
Nov-10-20 05:45PM  
05:21PM  
04:05PM  
02:30PM  
Nov-09-20 10:28AM  
Nov-03-20 04:05PM  
12:30PM  
Sep-03-20 08:47AM  
Aug-18-20 09:35AM  
Aug-11-20 05:35PM  
05:20PM  
04:05PM  
Aug-10-20 11:04AM  
Aug-04-20 04:05PM  
Jul-20-20 08:35AM  
Jun-15-20 12:00PM  
Jun-03-20 11:09AM  
May-27-20 06:00PM  
May-26-20 04:05PM  
May-22-20 07:30AM  
May-20-20 06:15PM  
04:05PM  
02:30PM  
May-15-20 04:40PM  
May-11-20 04:10PM  
May-05-20 12:30PM  
Apr-28-20 09:35AM  
Apr-17-20 08:37AM  
Apr-16-20 08:37AM  
Apr-07-20 05:00PM  
Apr-02-20 01:23PM  
Mar-31-20 05:00PM  
12:43PM  
Mar-23-20 05:00PM  
Mar-18-20 05:35PM  
04:05PM  
02:30PM  
Mar-17-20 09:35AM  
Mar-11-20 12:30PM  
Mar-06-20 04:35PM  
Mar-04-20 09:35AM  
Jan-07-20 04:05PM  
Jan-06-20 02:25PM  
Jan-02-20 09:35AM  
Dec-22-19 06:43PM  
Dec-04-19 09:21AM  
Dec-02-19 08:00AM  
Nov-25-19 09:35AM  
Nov-12-19 04:05PM  
Nov-05-19 05:45PM  
11:24AM  
10:32AM  
09:35AM  
Nov-02-19 10:30AM  
Oct-30-19 05:45PM  
Oct-24-19 05:45PM  
Oct-16-19 05:50PM  
Oct-15-19 09:35AM  
Oct-10-19 05:45PM  
Oct-04-19 05:45PM  
Sep-26-19 11:01AM  
Sep-25-19 12:25PM  
Sep-24-19 09:35AM  
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jones JamesDirectorDec 20Buy4.336528119,365Jan 07 05:14 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 20Buy4.333141,360178,473Jan 07 05:07 PM
Krogulski KennethDirectorDec 20Buy4.332761,195183,141Jan 07 05:08 PM
KAZIMI A JChairman and CEODec 20Buy4.33602605,770,563Jan 07 05:10 PM
Young CarolineDirectorDec 20Buy4.336026014,777Jan 07 05:12 PM
Young CarolineDirectorDec 17Buy4.175020814,717Jan 07 05:12 PM
KAZIMI A JChairman and CEODec 17Buy4.17502085,770,503Jan 07 05:10 PM
Krogulski KennethDirectorDec 17Buy4.172401,001182,865Jan 07 05:08 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 17Buy4.172401,001178,159Jan 07 05:07 PM
Jones JamesDirectorDec 17Buy4.175020819,300Jan 07 05:14 PM
Jones JamesDirectorDec 16Buy4.535022619,250Jan 07 05:14 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 16Buy4.532401,087177,919Jan 07 05:07 PM
Krogulski KennethDirectorDec 16Buy4.532401,087182,625Jan 07 05:08 PM
KAZIMI A JChairman and CEODec 16Buy4.53502265,770,453Jan 07 05:10 PM
Young CarolineDirectorDec 16Buy4.535022614,667Jan 07 05:12 PM
Young CarolineDirectorDec 15Buy4.293012914,617Jan 07 05:12 PM
KAZIMI A JChairman and CEODec 15Buy4.29301295,770,403Jan 07 05:10 PM
Krogulski KennethDirectorDec 15Buy4.29200858182,385Jan 07 05:08 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 15Buy4.29200858177,679Jan 07 05:07 PM
Jones JamesDirectorDec 15Buy4.293012919,200Jan 07 05:14 PM
Jones JamesDirectorDec 14Buy4.283012819,170Jan 07 05:14 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 14Buy4.28200856177,479Jan 07 05:07 PM
Krogulski KennethDirectorDec 14Buy4.28200856182,185Jan 07 05:08 PM
KAZIMI A JChairman and CEODec 14Buy4.28301285,770,373Jan 07 05:10 PM
Young CarolineDirectorDec 14Buy4.283012814,587Jan 07 05:12 PM
Young CarolineDirectorDec 13Buy4.363013114,557Jan 07 05:12 PM
KAZIMI A JChairman and CEODec 13Buy4.36301315,770,343Jan 07 05:10 PM
Krogulski KennethDirectorDec 13Buy4.36200872181,985Jan 07 05:08 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 13Buy4.36200872177,279Jan 07 05:07 PM
Jones JamesDirectorDec 13Buy4.363013119,140Jan 07 05:14 PM
Jones JamesDirectorDec 10Buy4.822110119,110Jan 07 05:14 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 10Buy4.8290434177,079Jan 07 05:07 PM
Krogulski KennethDirectorDec 10Buy4.8275362181,785Jan 07 05:08 PM
KAZIMI A JChairman and CEODec 10Buy4.8218875,770,313Jan 07 05:10 PM
Young CarolineDirectorDec 10Buy4.82188714,527Jan 07 05:12 PM
Young CarolineDirectorDec 09Buy5.811810514,509Jan 07 05:12 PM
KAZIMI A JChairman and CEODec 09Buy5.81181055,770,295Jan 07 05:10 PM
Krogulski KennethDirectorDec 09Buy5.8175436181,710Jan 07 05:08 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 09Buy5.8190523176,989Jan 07 05:07 PM
Jones JamesDirectorDec 09Buy5.812112219,089Jan 07 05:14 PM
Jones JamesDirectorDec 08Buy6.152112919,068Jan 07 05:14 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 08Buy6.1590554176,899Jan 07 05:07 PM
Krogulski KennethDirectorDec 08Buy6.1575461181,635Jan 07 05:08 PM
KAZIMI A JChairman and CEODec 08Buy6.15181115,770,277Jan 07 05:10 PM
Young CarolineDirectorDec 08Buy6.151811114,491Jan 07 05:12 PM
Young CarolineDirectorDec 07Buy5.611810114,473Jan 07 05:12 PM
KAZIMI A JChairman and CEODec 07Buy5.61181015,770,259Jan 07 05:10 PM
Krogulski KennethDirectorDec 07Buy5.6175421181,560Jan 07 05:08 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 07Buy5.6190505176,809Jan 07 05:07 PM
Jones JamesDirectorDec 07Buy5.612111819,047Jan 07 05:14 PM
Jones JamesDirectorDec 06Buy4.46219419,026Jan 07 05:14 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 06Buy4.4690401176,719Jan 07 05:07 PM
Krogulski KennethDirectorDec 06Buy4.4675334181,485Jan 07 05:08 PM
KAZIMI A JChairman and CEODec 06Buy4.4618805,770,241Jan 07 05:10 PM
Young CarolineDirectorDec 06Buy4.46188014,455Jan 07 05:12 PM
Young CarolineDirectorDec 03Buy4.47188014,437Jan 07 05:12 PM
KAZIMI A JChairman and CEODec 03Buy4.4718805,770,223Jan 07 05:10 PM
Krogulski KennethDirectorDec 03Buy4.4775335181,410Jan 07 05:08 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 03Buy4.4790402176,629Jan 07 05:07 PM
Jones JamesDirectorDec 03Buy4.47219419,005Jan 07 05:14 PM
Jones JamesDirectorDec 02Buy3.84218118,984Jan 07 05:14 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 02Buy3.8490346176,539Jan 07 05:07 PM
Krogulski KennethDirectorDec 02Buy3.8475288181,335Jan 07 05:08 PM
KAZIMI A JChairman and CEODec 02Buy3.8418695,770,205Jan 07 05:10 PM
Young CarolineDirectorDec 02Buy3.84186914,419Jan 07 05:12 PM
Young CarolineDirectorDec 01Buy4.14187514,401Jan 07 05:12 PM
KAZIMI A JChairman and CEODec 01Buy4.1418755,770,187Jan 07 05:10 PM
Krogulski KennethDirectorDec 01Buy4.1475310181,260Jan 07 05:08 PM
Cearnal Martin ESr VP/Chief Commercial OfficerDec 01Buy4.1490373176,449Jan 07 05:07 PM
Jones JamesDirectorDec 01Buy4.14218718,963Jan 07 05:14 PM
Krogulski KennethDirectorNov 30Buy4.61150692181,185Dec 03 05:07 PM
KAZIMI A JChairman and CEONov 30Buy4.61351615,770,169Dec 03 05:09 PM
Young CarolineDirectorNov 30Buy4.613516114,383Dec 03 05:10 PM
Jones JamesDirectorNov 30Buy4.614219418,942Dec 03 05:12 PM
Cearnal Martin ESr VP/Chief Commercial OfficerNov 30Buy4.61175807176,359Dec 03 05:05 PM
Krogulski KennethDirectorNov 29Buy2.23150334181,035Dec 03 05:07 PM
KAZIMI A JChairman and CEONov 29Buy2.2335785,770,134Dec 03 05:09 PM
Young CarolineDirectorNov 29Buy2.23357814,348Dec 03 05:10 PM
Jones JamesDirectorNov 29Buy2.23429418,900Dec 03 05:12 PM
Cearnal Martin ESr VP/Chief Commercial OfficerNov 29Buy2.23175390176,184Dec 03 05:05 PM
Krogulski KennethDirectorNov 26Buy2.26150339180,885Dec 03 05:07 PM
KAZIMI A JChairman and CEONov 26Buy2.2635795,770,099Dec 03 05:09 PM
Young CarolineDirectorNov 26Buy2.26357914,313Dec 03 05:10 PM
Jones JamesDirectorNov 26Buy2.26429518,858Dec 03 05:12 PM
Cearnal Martin ESr VP/Chief Commercial OfficerNov 26Buy2.26175395176,009Dec 03 05:05 PM
Krogulski KennethDirectorNov 24Buy2.31150346180,735Dec 03 05:07 PM
KAZIMI A JChairman and CEONov 24Buy2.3135815,770,064Dec 03 05:09 PM
Young CarolineDirectorNov 24Buy2.31358114,278Dec 03 05:10 PM
Jones JamesDirectorNov 24Buy2.31429718,816Dec 03 05:12 PM
Cearnal Martin ESr VP/Chief Commercial OfficerNov 24Buy2.31175404175,834Dec 03 05:05 PM
Krogulski KennethDirectorNov 23Buy2.2985195180,585Dec 03 05:07 PM
KAZIMI A JChairman and CEONov 23Buy2.2915345,770,029Dec 03 05:09 PM
Young CarolineDirectorNov 23Buy2.29153414,243Dec 03 05:10 PM
Jones JamesDirectorNov 23Buy2.29429618,774Dec 03 05:12 PM
Hamm John M.Chief Financial OfficerNov 23Buy2.353,8008,9306,800Dec 03 05:15 PM
Cearnal Martin ESr VP/Chief Commercial OfficerNov 23Buy2.29105240175,659Dec 03 05:05 PM
KAZIMI A JChairman and CEONov 22Buy2.3515355,770,014Dec 03 05:09 PM
Krogulski KennethDirectorNov 22Buy2.3585200180,500Dec 03 05:07 PM
Young CarolineDirectorNov 22Buy2.35153514,228Dec 03 05:10 PM
Jones JamesDirectorNov 22Buy2.35429918,732Dec 03 05:12 PM